Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion type Assertion NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_head.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion evidence source_evidence_literature NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion SIO_000772 23504048 NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion wasDerivedFrom befree-20150227 NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.
- NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_assertion wasGeneratedBy ECO_0000203 NP925808.RArMHz8NQf0IDqhiKE0d872piNqUK5AFbtonbG9p_pUk8130_provenance.